Schedule your Pfizer COVID-19 vaccine Monday through Thursday from 8 a.m. - 5 p.m. and Friday from 8 a.m. - noon.  Learn more >

Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST)

Investigator: Raj Satkunasivam, MD

Study Coordinator: Cinthya Yesenia Obando Perez

Status: Enrolling

ClinicalTrials.gov Number: NCT04165317

Phone: 346.238.6123

Protocol Number: PRO00024845

Description

Primary Purpose: Treatment
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials